TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis By Cancer History Project December 27, 2013
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL By Cancer History Project December 27, 2013
TCL Archive Biomarker May Predict Prostate Cancer Metastases By Cancer History Project December 27, 2013
TCL Archive Individualized Cancer Vaccines Show 90% Survival at 6 Months By Cancer History Project December 27, 2013
TCL Archive Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial By Cancer History Project December 27, 2013
TCL Archive Two Phase II Studies of Ibrutinib Deliver High Response Rates By Cancer History Project December 27, 2013
TCL Archive NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent By Cancer History Project December 27, 2013
TCL Archive Study: BRCA2-Negative Women Could Still Have High Risk By Cancer History Project December 27, 2013
PeopleSpotlight Article Felix Feng: The Feng Symposium on Prostate Cancer Revolutions Special Lecture By Cancer History Project
